caris life sciences - Search News

News

Caris Life Sciences, IPO

Fast Company on MSN · 5d

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

The cancer diagnostics and treatment company priced above its previously planned range and might signal a renewed appetite for biotech IPOs.

Bloomberg · 5d

Caris Life Sciences IPO Prices Above Range to Raise $494 Million

Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, raised $494 million in a US initial public offering that priced above the top of its marketed range.

CNBC on MSN · 5d

Caris Life Sciences CEO on IPO debut, using AI to fight against cancer

David Dean Halbert, Caris Life Sciences chairman, founder and CEO, joins 'Squawk Box' to discuss the company's IPO debut, how the company uses AI technology to help diagnose and treat cancer,

5d

Caris Life Sciences Announces Pricing of Initial Public Offering

Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, ...

Caris settles IPO at $21, trading starts at $28

Despite raising the price of its IPO twice, Caris Life Sciences Inc. left money on the table with a 33% increase in price as ...

4don MSN

Sixth Street-backed Caris Life valued at $7.66 billion in strong Nasdaq debut

Caris Life Sciences' shares jumped nearly 29% in their New York debut on Wednesday, fetching the cancer diagnostic firm a ...

4don MSN

This ‘AI TechBio’ company goes public as IPO demand spreads to biotech

Shares of Caris Life Sciences soared in their public debut Wednesday, as investors bought into the company’s business of ...

Caris swells its planned IPO, seeking $5.7bn valuation

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results